Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Paediatr Int Child Health ; 37(1): 74-77, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27077634

ABSTRACT

Epstein-Barr virus (EBV) infection results in a spectrum of clinical manifestations. The host immune response to EBV plays a key role in the extent and degree of clinical features, which in children under 4 years of age are usually mild, non-specific and self-limiting. A 2-year-old boy in whom no known immune disorder could be found presented with acute acalculous cholecystitis, renal dysfunction with massive proteinuria, ascites, pleural effusion, minimal peripheral oedema and a severe systemic inflammatory response. Improvement occurred after initiation of corticosteroids and antiviral treatment with gancyclovir. In severely symptomatic or complicated EBV infection, a primary immunodeficiency must be suspected. If a primary immunodeficiency has been ruled out, the correct management of severe EBV infection in the immunocompetent host remains controversial.


Subject(s)
Cholecystitis/complications , Cholecystitis/etiology , Epstein-Barr Virus Infections/complications , Epstein-Barr Virus Infections/diagnosis , Herpesvirus 4, Human/isolation & purification , Nephrotic Syndrome/complications , Nephrotic Syndrome/etiology , Adrenal Cortex Hormones/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Antiviral Agents/administration & dosage , Child, Preschool , Cholecystitis/drug therapy , Cholecystitis/pathology , Epstein-Barr Virus Infections/drug therapy , Epstein-Barr Virus Infections/pathology , Ganciclovir/administration & dosage , Humans , Male , Nephrotic Syndrome/drug therapy , Nephrotic Syndrome/pathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...